MTAs for live animals or custom antibodies must have protocol(s) reviewed and approved by the Animal Care and Use Committee.
MTAs for human tissue must have protocol(s) reviewed by the Committee for the Protection of Human Subjects.
MTAs for hazardous materials and/or select agents must follow EH&S compliance procedures.
MTAs where the decision to undertake the research is based on receiving access to the material(s) from a nongovernmental provider must follow Conflict of Interest Committee requirements for financial disclosure.